KR840007227A - 피라지노[2',3'-3,4] 피리도 [1,2-a] 인돌 유도체의 제조방법 - Google Patents

피라지노[2',3'-3,4] 피리도 [1,2-a] 인돌 유도체의 제조방법 Download PDF

Info

Publication number
KR840007227A
KR840007227A KR1019840000347A KR840000347A KR840007227A KR 840007227 A KR840007227 A KR 840007227A KR 1019840000347 A KR1019840000347 A KR 1019840000347A KR 840000347 A KR840000347 A KR 840000347A KR 840007227 A KR840007227 A KR 840007227A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
compound
pyrido
indole
Prior art date
Application number
KR1019840000347A
Other languages
English (en)
Inventor
샌트록크(외 1) 죠지
Original Assignee
존 지. 호스만
아메리칸 홈프로덕츠 코오포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 존 지. 호스만, 아메리칸 홈프로덕츠 코오포레이션 filed Critical 존 지. 호스만
Publication of KR840007227A publication Critical patent/KR840007227A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

피라지노 [2′,3′-3,4] 피리도 [1,2-a] 인돌 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 일반식(Ⅱ)의 화합물을 폐환시켜 R3및 R4가 동일한 저급알킬인 상응하는 일반식(Ib)의 화합물을 수득하고; 일반식(Ⅲ)의 화합물을 수소화시켜 R3및 R4가 수소인 상응하는 일반식(Ib)의 화합물을 수득하며; 일반식(Ⅳ)의 화합물을 에메렌메아민과 축합시킨 후, 생성된 중간체를 환원시켜 R3및 R4가 수소인 상응하는 일반식(Ia)의 화합물을 수득하고; R3및 R4가 수소인 일반식(Ⅰ)의 화합물을 임의의 순서로 알킬화, 아실화 및/또는 환원시켜 상응하는 일반식(Ⅰ)의 화합물을 수득하며; 일반식(Ⅰ)의 화합물을 치료학적으로 무독한 산과 반응시켜 상응하는 일반식(Ⅰ)의 화합물을 치료학적으로 무독한 산과의 염으로서 수득함을 특징으로 하여 일반식(Ⅰ)의 화합물을 또는 그의 치료학적으로 무독한 산부가염을 제조하는 방법.
    상기식에서, R1은 수소, 할로겐, 저급알킬, 저급알콕시 또는 트리플루오로메틸이고, R2는 수소 또는 탄소수 1 내지 3의 저급 알킬이며, R3및 R4는 각기 수소, 저급알킬, 저급 알케닐, 저급 알키닐, 사이클로(저급)알킬, 저급 알카노일, 하이드록시(저급)알킬, 저급 알콕시카보닐(저급) 알킬, 페닐(저급)알킬 또는 페녹시(저급)알킬이고, R5는 저급 알킬이며, X는 브로모 또는 클로로이다.
  2. 제1항에 있어서, R1이 수소 또는 브로모이며, R2가 메틸이고, R3가 수소, 저급알킬, 저급 알카노일, 하이드록시(저급)알킬 또는 저급알콕시카보닐(저급)알킬이며, R4가 수소, 저급알킬, 저급알키닐, 하이드록시(저급)알킬 또는 저급 알콕시카보닐(저급)알킬인 다음 일반식(Ⅰ)의 화합물 또는 그의 치료학적으로 무독한 산부가염을 제조하는 방법.
  3. 제2항에 있어서, R1이 수소이고, R2가 메틸이며, R3가 수소, 저급알킬 또는 하이드록시(저급)알킬이고, R4가 수소, 저급알킬, 저급 알키닐 또는 하이드록시(저급)알킬인 방법.
  4. 제1항에 있어서, 제조된 일반식(Ⅰ)의 화합물이 (4a-12a-트란스)-5-메틸-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2′,3′-3,4] 피리도[1,2-a] 인돌;
    (4a,12a-트란스)-1,4-디에틸-5-메틸-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4]
    피리도[1,2-a] 인돌;
    (4a,12a-트란스)-5-메틸-1,4-티피로필-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4]
    피리도[1,2-a] 인돌;
    (4a,12a-트란스)-1,4,5-트리메틸-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4]
    피리도[1,2-a] 인돌; 및 (4a-12a-트란스)-5-메틸-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2′,3′-3,4] 피리도[1,2-a] 인돌-1,4-디에탄올인 방법.
  5. 제1항에 있어서, 제조된 일반식(Ⅰ)의 화합물이 (4a,12a-트란스)-1-에틸-5-메틸-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4] 피리도[1,2-a] 인돌;
    (4a,12a-트란스)-5-메틸-1-(1-메틸에틸)-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4]
    피리도[1,2-a] 인돌;
    (4a,12a-트란스)-5-메틸-1-(2-프로피닐)-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4]
    피리도[1,2-a] 인돌;
    (4a,12a-트란스)-1-에틸-5-메틸-4프로필-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4]
    피리도[1,2-a] 인돌;
    (4a,12a-트란스)-4-부틸-1-에틸-5-1,2,3,4,4a,11,12,12a-메틸옥타하이드로피라지노[2',3'-3,4]
    피리도[1,2-a] 인돌;
    (4a,12a-트란스)-4-에틸-5-메틸-1-(1-메틸에틸)-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4]
    피리도[1,2-a] 인돌; 및 (4a,12a-트란스)-5-메틸-1-(1-메틸에틸)-4-프로필-1,2,3,4,4a,11,12,12a-옥타하이드로피라지노[2',3'-3,4] 피리도[1,2-a] 인돌인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840000347A 1983-01-26 1984-01-26 피라지노[2',3'-3,4] 피리도 [1,2-a] 인돌 유도체의 제조방법 KR840007227A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US461095 1983-01-26
US06/461,095 US4482714A (en) 1983-01-26 1983-01-26 Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives

Publications (1)

Publication Number Publication Date
KR840007227A true KR840007227A (ko) 1984-12-06

Family

ID=23831210

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840000347A KR840007227A (ko) 1983-01-26 1984-01-26 피라지노[2',3'-3,4] 피리도 [1,2-a] 인돌 유도체의 제조방법

Country Status (10)

Country Link
US (1) US4482714A (ko)
EP (1) EP0115920A3 (ko)
JP (1) JPS59141580A (ko)
KR (1) KR840007227A (ko)
AU (1) AU2376884A (ko)
DK (1) DK33684A (ko)
ES (1) ES8707532A1 (ko)
GR (1) GR81736B (ko)
IE (1) IE840119L (ko)
ZA (1) ZA84394B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515949A (en) * 1983-01-26 1985-05-07 American Home Products Corporation [2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals
US4624954A (en) * 1985-12-20 1986-11-25 American Home Products Corporation 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof, useful for the treatment of cognitive impairments
US4665183A (en) * 1985-12-20 1987-05-12 American Home Products Corp. Process for preparing 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof useful for the treatment of cognitive impairments
US7297289B2 (en) * 2001-03-26 2007-11-20 Nisshinbo Industries, Inc. Ionic liquids, electrolyte salts for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644384A (en) * 1969-06-09 1972-02-22 Sterling Drug Inc Certain 2-(alpha-haloacetyl) - 1 2 3 4-tetrahydro - 9h - pyrido(3 4-b)indole-3-carboxylates and derivatives
US3850934A (en) * 1973-06-08 1974-11-26 Hoffmann La Roche 6,7,8,9-tetrahydro-7a,11a-ethanooxyindolo(1,2-h)(1,7)naphthyridin-10(11h)-ones
DE2703920A1 (de) * 1976-02-05 1977-08-11 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung

Also Published As

Publication number Publication date
US4482714A (en) 1984-11-13
GR81736B (ko) 1984-12-12
DK33684A (da) 1984-07-27
IE840119L (en) 1984-07-26
EP0115920A2 (en) 1984-08-15
JPS59141580A (ja) 1984-08-14
ES529131A0 (es) 1985-11-16
ZA84394B (en) 1985-09-25
AU2376884A (en) 1984-08-02
ES8707532A1 (es) 1985-11-16
DK33684D0 (da) 1984-01-25
EP0115920A3 (en) 1986-02-05

Similar Documents

Publication Publication Date Title
KR870004030A (ko) 축합 이미다조 피리딘 유도체
JPS5524165A (en) Alkyl derivative of cc076 compound
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
KR860002496A (ko) 카보닐 화합물의 제조방법
KR840006475A (ko) 나프탈렌 유도체의 제조방법
KR840007227A (ko) 피라지노[2',3'-3,4] 피리도 [1,2-a] 인돌 유도체의 제조방법
KR840009104A (ko) 2'-데옥시-5-치환우리딘 유도체의 제조방법
KR840006482A (ko) 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법
KR890008110A (ko) 피리미딘 유도체
KR870003054A (ko) 사이클로 알킬-치환된 4-아미노 페닐 유도체의 제조 방법
PT90106A (pt) Processo para a preparacao de derivados de avermectina antiparasiticos
KR890008121A (ko) 로다닌 유도체 및 약제학적 조성물
PH16523A (en) 2,3,6,7-tetrahydrothiazolo(3,2-a)pyrimidine derivatives
KR830001900A (ko) 페닐모르판과 그의 중간물질및 제조방법
KR870005011A (ko) 디플루오로사이클로스타틴 함유 폴리펩티드 유도체의 제조방법
KR850006406A (ko) 4,7-디히드로피라졸[3,4-b] 피리딘 유도체의 제조방법
KR850004760A (ko) 이미다조 퀴놀린 유도체의 제조방법
KR870002118A (ko) 벤질아민 유도체 및 그 제조방법
KR860006461A (ko) 항알레르기 작용을 갖는 화합물의 제조방법
KR890002011A (ko) 5-할로 게노-6-아미노-니코틴산 할라이드. 이의 제조방법 및 용도
HUT50833A (en) Process for producing indolo/3,2-1-de/ /1,4/-oxazino/2,3,4-ij/ /1,5/-naphthyridine derivatives
KR890013034A (ko) 트리사이클릭 트리아졸로피리미딘 유도체
KR830006292A (ko) 이미다조퀴나졸린 유도체의 제조방법
KR880013900A (ko) 3-아실아미노메틸-5,6,7,8-테트라히드로이미다조[1,2-a]피리딘유도체 그의 제법 및 치료에의 응용
KR870010061A (ko) 세팔로스포린 유도체의 제조방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid